Collaborations Pharmaceuticals, Inc. offers drug discovery skills tailored to rare and neglected diseases. Given our domain knowledge, we have noted the need for computational, chemical, and biological capabilities as foundations and patient-driven collaborations seek to translate a therapeutic concept. We share this desire and drive to bring therapies to market.
We provide decades of drug discovery experience and can use our computational approach to design and score new compounds versus targets and properties of interest.
We will work with disease foundations, academics or companies to increase the probability of successful outcomes.
A key aspect of bringing a therapy to market is finding the initial funds to make this happen. We have a proven track record of obtaining funding through the NIH and DOD.
We focus on obtaining FDA orphan drug designations to provide some additional exclusivity and benefits. To date we have received three.